Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tara L Lin

Showing results (31-40 of 84) with videos related to

Pageof 9
Sort By:
Frontiers in Oncology|January 31, 2022
<i>Post-hoc</i> Analysis of Pharmacodynamics and Single-Agent Activity of CD3xCD123 Bispecific Antibody APVO436 in Relapsed/Refractory AML and MDS Resistant to HMA or Venetoclax Plus HMAJustin Watts, Tara L Lin, Alice Mims, et al.
Cancers|August 27, 2021
A Clinical Phase 1B Study of the CD3xCD123 Bispecific Antibody APVO436 in Patients with Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic SyndromeFatih M Uckun, Tara L Lin, Alice S Mims, et al.
Annals of Hematology|November 2, 2018
Long-term results of a pilot study evaluating hyperbaric oxygen therapy to improve umbilical cord blood engraftmentAlain Mina, Leyla Shune, Haitham Abdelhakim, et al.
Leukemia & Lymphoma|February 28, 2020
Final safety and efficacy results from the CPX-351 early access program for older patients with high-risk or secondary acute myeloid leukemiaGail J Roboz, Melissa L Larson, S Eric Rubenstein, et al.
Leukemia|September 15, 2025
Downregulation of MICA/MICB improves cell persistence and clinical activity of NKG2DL CAR T-cells in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic neoplasiaDaniel Pollyea, Tessa Kerre, Dries Deeren, et al.
Journal of Clinical Apheresis|June 3, 2015
Effect of extracorporeal photopheresis on lung function decline for severe bronchiolitis obliterans syndrome following allogeneic stem cell transplantationKyle R Brownback, Steven Q Simpson, Lucas R Pitts, et al.
Plos One|January 5, 2011
Self-renewal of acute lymphocytic leukemia cells is limited by the Hedgehog pathway inhibitors cyclopamine and IPI-926Tara L Lin, Qiuju H Wang, Patrick Brown, et al.
Contemporary Clinical Trials Communications|February 29, 2024
Using Bayesian hierarchical modeling for performance evaluation of clinical trial accrual for a cancer centerXiaosong Shi, Dinesh Pal Mudaranthakam, Jo A Wick, et al.
Blood Advances|October 17, 2024
Lower-intensity CPX-351 plus venetoclax induction for adults with newly diagnosed AML unfit for intensive chemotherapyGeoffrey L Uy, Vinod Pullarkat, Praneeth Baratam, et al.
Leukemia & Lymphoma|August 17, 2023
Multi-institutional analysis of outcomes in acute myeloid leukemia patients with central nervous system involvementDahniel Sastow, Joshua Tatarian, Yosef J R A Riazat-Kesh, et al.
Pageof 9

Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
Frontiers in Oncology|January 31, 2022
<i>Post-hoc</i> Analysis of Pharmacodynamics and Single-Agent Activity of CD3xCD123 Bispecific Antibody APVO436 in Relapsed/Refractory AML and MDS Resistant to HMA or Venetoclax Plus HMAJustin Watts, Tara L Lin, Alice Mims, et al.
Cancers|August 27, 2021
A Clinical Phase 1B Study of the CD3xCD123 Bispecific Antibody APVO436 in Patients with Relapsed/Refractory Acute Myeloid Leukemia or Myelodysplastic SyndromeFatih M Uckun, Tara L Lin, Alice S Mims, et al.
Annals of Hematology|November 2, 2018
Long-term results of a pilot study evaluating hyperbaric oxygen therapy to improve umbilical cord blood engraftmentAlain Mina, Leyla Shune, Haitham Abdelhakim, et al.
Leukemia & Lymphoma|February 28, 2020
Final safety and efficacy results from the CPX-351 early access program for older patients with high-risk or secondary acute myeloid leukemiaGail J Roboz, Melissa L Larson, S Eric Rubenstein, et al.
Leukemia|September 15, 2025
Downregulation of MICA/MICB improves cell persistence and clinical activity of NKG2DL CAR T-cells in patients with relapsed or refractory acute myeloid leukemia or myelodysplastic neoplasiaDaniel Pollyea, Tessa Kerre, Dries Deeren, et al.
Journal of Clinical Apheresis|June 3, 2015
Effect of extracorporeal photopheresis on lung function decline for severe bronchiolitis obliterans syndrome following allogeneic stem cell transplantationKyle R Brownback, Steven Q Simpson, Lucas R Pitts, et al.
Plos One|January 5, 2011
Self-renewal of acute lymphocytic leukemia cells is limited by the Hedgehog pathway inhibitors cyclopamine and IPI-926Tara L Lin, Qiuju H Wang, Patrick Brown, et al.
Contemporary Clinical Trials Communications|February 29, 2024
Using Bayesian hierarchical modeling for performance evaluation of clinical trial accrual for a cancer centerXiaosong Shi, Dinesh Pal Mudaranthakam, Jo A Wick, et al.
Blood Advances|October 17, 2024
Lower-intensity CPX-351 plus venetoclax induction for adults with newly diagnosed AML unfit for intensive chemotherapyGeoffrey L Uy, Vinod Pullarkat, Praneeth Baratam, et al.
Leukemia & Lymphoma|August 17, 2023
Multi-institutional analysis of outcomes in acute myeloid leukemia patients with central nervous system involvementDahniel Sastow, Joshua Tatarian, Yosef J R A Riazat-Kesh, et al.
Pageof 9